Invitation to Press Conference and Photo Opportunity: Hope for 200 Million Malaria Patients
New Synthesis Process Holds Promise for Low-cost Drugs / Presentation on Tuesday, January 17, 11 a.m., at Freie Universität Berlin (Fabeckstr. 34–36, 14195 Berlin)
№ 6/2012 from Jan 11, 2012
For the more than 200 million people worldwide who are suffering from malaria, there is new hope for inexpensive and easily available drugs. Chemists working at the Max Planck Institute of Colloids and Interfaces and Freie Universität Berlin have developed a novel synthesis process for the most effective malaria drug.
The ingenious synthesis, its global relevance, and the very simple apparatus which is required will be presented
at a press conference / photo opportunity
on Tuesday, January 17, 2012, at 11:00 a.m.
Institute of Chemistry and Biochemistry, Freie Universität Berlin (Fabeckstr. 34 – 36, large seminar room in area of Inorganic Chemistry; 14195 Berlin)
by Prof. Dr. Peter H. Seeberger, director of the Max Planck Institute of Colloids and Interfaces in Potsdam and a chemistry professor at Freie Universität Berlin.
Each year one million individuals die from malaria because they do not have access to malaria medication or cannot afford it. Although the Bill and Melinda Gates Foundation and the Clinton Foundation have contributed several hundred million dollars to the battle against malaria, and the latter subsidizes the supply of malaria drugs in some countries, these efforts can only alleviate the problem, but not eliminate it. That could change through the use of a new chemical method for producing the best currently available malaria drug.
Please register by sending an email (email@example.com) or fax (030 / 838-73187) to the Office of News and Public Affairs by Monday, January 16, 2012.
If you have any questions, please contact the Max Planck Institute of Colloids and Interfaces, Potsdam
- Frank Grimm, Tel.: 0331 / 567-9203
- Dirk Pohlmann, Tel.: 0171/6851813
or Freie Universität Berlin
Carsten Wette, Tel. 030 / 838-73189